Accent Microcell Limited

ACCENTMIC

INE0Q5D01013

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:51 2024-05-31 am EDT			5-day change	1st Jan Change
270.6 ^INR	-1.51%		-5.91%	-7.47%

Mar. 02	Accent Microcell Limited Receives Purchase Order from N. G. P Tobacco ApS, Denmark	CI
Feb. 27	Accent Microcell Limited Announces Constitution of Investment, Finance and Business Development Committee	CI

Accent Microcell Limited Recommends Dividend for the Financial Year Ended 31 March, 2024

May 17, 2024 at 05:18 am EDT

Accent Microcell Limited announced that at its Board of Directors meeting held on May 17, 2024, recommended a final dividend at the rate of 10% on the Equity share capital of the company i.e. INR 1/- per equity share of INR 10/- each for the financial year ended 31 March, 2024, subject to the approval of shareholders at the Annual General Meeting of the Company.

Latest news about Accent Microcell Limited

Accent Microcell Limited Receives Purchase Order from N. G. P Tobacco ApS, Denmark	Mar. 02	CI
Accent Microcell Limited Announces Constitution of Investment, Finance and Business Development Committee	Feb. 27	CI
Accent Microcell Limited has completed an IPO in the amount of INR 784 million.	Dec. 12	CI

Chart Accent Microcell Limited

Duration

Period

More charts

Company Profile

Accent Microcell Limited is engaged in developing, processing, refining, producing, manufacturing, or buying, importing, stocking, and marketing, selling, exporting, and generally dealing in all kinds of drugs and medicines. The Companyâs segments include Pharmaceuticals, Nutraceuticals, and Food. Its drugs and medicines include bulk drugs, pharmaceutical formulations in all forms, feed supplements and dietary food supplements and food preparations in allopathic, ayurvedic, umami, homeopathic or other branches of healthcare and treatment of human beings and veterinary applications, antibiotics, herbal, bacteriological and biological products, insecticides, pesticides, fungicides, disinfectants and vermin fugs and raw materials, ingredients, intermediates, semi-finished or finished preparations, compounds, pharmaceutical chemical and microcrystalline cellulose powder, alpha cellulose powder and all kinds of products and by-products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ACCENT MICROCELL LIMITED	-7.47%	68.22M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B